The Effect of Anti-bacterial Honey Dressing on the Healing of Split Thickness Skin Graft Donor Site

August 14, 2019 updated by: HaEmek Medical Center, Israel

The study, "Evaluation of the effect of antibacterial medical honey dressing for healing of implants donor area", is a Phase 4 Study, Prospective, A randomized trial, 3 arms (treatment groups) trial, Open-label, non-controlled, non-randomized, Aims To test the effectiveness of antibacterial medical honey dressing in the therapy of donor area of implants. In our Research Will participate in 135 new patients over the age of 18, with a wound in the donor area of hip implants, Hospitalized in the Plastic Surgery Unit of the "Haemek" Medical Center. Appropriate patients, who will agree to sign and sign a consent form, be assigned randomly to one of three treatment groups:

  1. The research group: Medihoney antibacterial wound dressing.
  2. The control group: Paraffin gauze with saline- The basic treatment in the donor site, accepted the literature.
  3. Comparison group: Polymem dressing - Common treatment in the donor site in the Plastic Surgery Unit of the "Haemek" Medical Center.

Participants in the three study groups will be performed, each visit, Medical monitoring and examination by a team of medical indices of Plastic Surgery Unit, as is customary. The treatment will be performed, twice a week until recovery and the complete closure of the wound.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Study protocol The aim of this study is to evaluate "The effect of anti-bacterial honey dressing on the healing of split thickness skin graft donor site".

Protocol Abstract. The use of skin grafts for wound closure is considered one of the common methods in the field of plastic surgery. Healing of the donor area is secondary, gradual and is a serious problem, Associated with a high percentage of wound infections, Delay in healing, Scars, Pain unpleasant odor and other problems. As of today, there is no ideal treatment to cure the donor area of implants, due to lack of high-quality comparative studies. The use of honey to treat wounds known for centuries in different cultures. Honey has anti-inflammatory and anti-bacterial effect, Debridement ability, and Pain relief. Honey has almost no side effects. Effectiveness of honey in wound healing has been tested in many clinical trials, but most of them and some methodological problems of low quality. Therefore, it is difficult to conclude that the existing information handling guidelines and recommending further clinical research.

The study, "Evaluation of the effect of antibacterial medical honey dressing for healing of implants donor area", is a Phase 4 Study, Prospective, A randomized trial, 3 arms (treatment groups) trial, Open-label, non-controlled, non-randomized, Aims To test the effectiveness of antibacterial medical honey dressing in the therapy of donor area of implants. In our Research Will participate in 135 new patients over the age of 18, with a wound in the donor area of hip implants, Hospitalized in the Plastic Surgery Unit of the "Haemek" Medical Center. Appropriate patients, who will agree to sign and sign a consent form, be assigned randomly to one of three treatment groups:

  1. The research group: Medihoney antibacterial wound dressing.
  2. The control group: Paraffin gauze with saline- The basic treatment in the donor site, accepted the literature.
  3. Comparison group: Polymem dressing - Common treatment in the donor site in the Plastic Surgery Unit of the "Haemek" Medical Center.

Participants in the three study groups will be performed, each visit, Medical monitoring and examination by a team of medical indices of Plastic Surgery Unit, as is customary. The treatment will be performed, twice a week until recovery and the complete closure of the wound.

Research Goals Primary goal Examining the effect of Medihoney antibacterial wound dressing honey on the duration of the donor site area healing, until full recovery and wound closure.

Secondary objectives

  1. To Evaluatee the effect of Medihoney antibacterial wound dressing on pain intensity donor site.
  2. . To Evaluatee the effect of Medihoney antibacterial wound dressing on the frequency of infections in donor site.

Tertiary goal

  1. To evaluate the effect of Medihoney antibacterial wound dressing on the unpleasant odor in the donor site.
  2. 2. To evaluate the effect of Medihoney antibacterial wound dressing on patient satisfaction from treatment in donor site.

Research Hypothesis Medihoney antibacterial wound dressing will find significantly statistical more effective in comparison with Paraffin gauze with saline dressing and compared with Polymem dressing, In terms of duration of a treatment, Intensity of pain and the prevalence of infection in the donor site.

Treatment regimen First group Immediately after harvesting the skin, the donor site will be covered with a thin layer of Medihoney Antibacterial Wound Gel and Xtrasorb Super Absorbent Dressing will used as secondary dressing. After 24 hours, the dressing will be replaced by Medihoney HCS dressing.

Medihoney HCS dressing will be replace twice a week.

Study Type

Interventional

Enrollment (Anticipated)

135

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • 'Afula, Israel, 18341111
        • Recruiting
        • HaEmekMC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with a wound on the hip - the implant donor area
  • Wound size up to 100 sm²

Exclusion Criteria:

  • Known sensitivity of the patient to honey
  • Pregnant women
  • Patients under 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: research group
Medihoney Dressing
to evaluate the effect of medihoney dressing on the healing of split thickness skin graft donor site
NO_INTERVENTION: control group
Paraffin gauze with saline Dressing
NO_INTERVENTION: 3. Comparison group
Polymem dressing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Examining the effect of Medihoney antibacterial wound dressing honey on the duration of the donor site area healing, until full recovery and wound closure
Time Frame: 25 days
The Outcome will be assessed by Medical examination and Laboratory Testing
25 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To Evaluatee the effect of Medihoney antibacterial wound dressing on the frequency of infections in donor site.
Time Frame: 25 days
The Outcome will be assessed by Medical examination and Laboratory Testing
25 days
To Evaluatee the effect of Medihoney antibacterial wound dressing on pain intensity donor site.
Time Frame: 25 days
The Outcome will be assessed by Medical examination and Questionnaire
25 days
To evaluate the effect of Medihoney antibacterial wound dressing on the unpleasant odor in the donor site.
Time Frame: 25 days
The Outcome will be assessed by Medical examination and Questionnaire
25 days
To evaluate the effect of Medihoney antibacterial wound dressing on patient satisfaction from treatment in donor site.
Time Frame: 25 days
The Outcome will be assessed by Medical examination and Questionnaire
25 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aziz Shufani, MD, HaEmek Medical Center, Afula

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (ANTICIPATED)

January 1, 2020

Study Completion (ANTICIPATED)

January 1, 2020

Study Registration Dates

First Submitted

February 10, 2015

First Submitted That Met QC Criteria

March 23, 2015

First Posted (ESTIMATE)

March 27, 2015

Study Record Updates

Last Update Posted (ACTUAL)

August 16, 2019

Last Update Submitted That Met QC Criteria

August 14, 2019

Last Verified

August 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0079-14

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disorder of Skin Donor Site

Clinical Trials on medihoney dressing

Subscribe